Familial Risk for Moyamoya Disease Among First-Degree Relatives, Based on a Population-Based Aggregation Study in Korea

Clinical and Molecular Features of 5 European Multigenerational Families With Moyamoya Angiopathy

(2019) Lou Grangeon et al.   STROKE

Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease

(2016) Eun-Hee Kim et al.   JOURNAL OF NEUROSURGERY

The Pathophysiology of Moyamoya Disease: An Update

(2016) Oh Young Bang et al.   Journal of Stroke

Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis

(2016) Jong S. Kim   Journal of Stroke

Prospective Screening of Family Members with Moyamoya Disease Patients

(2014) Cong Han et al.   PLoS One

Incidence, Prevalence, and Survival of Moyamoya Disease in Korea

(2014) Il Min Ahn et al.   STROKE

RNF213 Rare Variants in an Ethnically Diverse Population With Moyamoya Disease

(2014) Alana C. Cecchi et al.   STROKE

Genetics and Biomarkers of Moyamoya Disease: Significance ofRNF213as a Susceptibility Gene

(2014) Miki Fujimura et al.   Journal of Stroke

Homozygous c.l4576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease

(2012) S. Miyatake et al.   NEUROLOGY

Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population

(2012) Zhiyuan Wu et al.   PLoS One

Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development

(2011) Wanyang Liu et al.   PLoS One

A genome-wide association study identifies RNF213 as the first Moyamoya disease gene

(2010) Fumiaki Kamada et al.   JOURNAL OF HUMAN GENETICS

Moyamoya Disease and Moyamoya Syndrome

(2009) R. Michael Scott et al.   NEW ENGLAND JOURNAL OF MEDICINE

Autosomal dominant moyamoya disease maps to chromosome 17q25.3

(2008) Y. Mineharu et al.   NEUROLOGY